Literature DB >> 2412050

Continuous inhibition of platelet S2-serotonergic receptors during chronic administration of ketanserin in humans.

F De Clerck, B Xhonneux.   

Abstract

Platelet aggregation induced by serotonin in plasma obtained from 9 volunteers was inhibited at 90 min and 15 h after the oral administration of ketanserin, either acutely or after one week of chronic administration. At 7 days after the last dose, a transient overreaction to serotonin occurred. Platelet reactions to epinephrine, collagen and adenosine diphosphate were not affected by ketanserin. The present results demonstrate a continuous inhibition of S2-serotonergic receptors in platelets during both acute and chronic treatment with ketanserin in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412050     DOI: 10.1097/00005344-198500077-00007

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Effect of chronic ketanserin treatment on serotonin-induced platelet aggregation in patients with Raynaud's phenomenon.

Authors:  B Marasini; M L Biondi; R Mollica
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

3.  The effects of the 5 HT2 antagonist ketanserin in adult atopic asthma.

Authors:  D J Stott; J A Roberts; N C Thomson; S G Ball
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Ketanserin and the arterial baroreceptor reflex in normotensive subjects.

Authors:  A Berdeaux; A Edouard; K Samii; J F Giudicelli
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.